Related Experiment Video

Updated: Aug 24, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

[Effect of curcumin on STAT5 signaling molecule in K562 cells]

Wei-Hong Chen1, Yan Chen, Jun-Xia Gu

  • 1Department of Hematology, Affiliated Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
|June 9, 2004
PubMed
Abstract

Insights

Curcumin effectively inhibits K562 cell proliferation by reducing STAT5 (Signal Transducer and Activator of Transcription 5) mRNA and protein expression. This study reveals curcumin's potential as an antileukemia agent.

Area of Science:

  • Molecular Biology
  • Pharmacology

Context:

  • K562 cells are a human chronic myeloid leukemia cell line.
  • STAT5 signaling is implicated in various cancers, including leukemia.
  • Curcumin, a compound from turmeric, exhibits potential anti-cancer properties.

Purpose:

  • To investigate the anti-leukemic effects of curcumin on K562 cells.
  • To elucidate the role of STAT5 signaling in curcumin's mechanism of action.
  • To determine the impact of curcumin on STAT5 mRNA and protein expression.

Summary:

  • Curcumin significantly inhibited K562 cell proliferation in a dose- and time-dependent manner.
  • Curcumin treatment led to a significant reduction in STAT5 mRNA and protein levels in K562 cells.
  • The percentage of STAT5-positive cells and the expression level of STAT5 protein were markedly decreased in the curcumin-treated group.

Impact:

  • Curcumin demonstrates potent anti-leukemic activity against K562 cells.
  • Inhibition of STAT5 signaling is a key mechanism underlying curcumin's anti-leukemic effects.
  • These findings support the potential therapeutic application of curcumin in treating chronic myeloid leukemia.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...